Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Niklaus Scaefer"'
Autor:
Clarisse Dromain, Marianne Pavel, Frederico Costa, Anders Sundin, Eric Baudin, Niklaus Scaefer, Louis de Mestier, Hector Vidal Trueba, Naik Vietti Violi, Philip Borg, Regis Otaviano Franca Bezerra, Luciana Carvhalo, Pavan Najran, Daniela Pezzutti, Carlos Lopez Lopez, Marta Opalinska, Joakim Crona, Salma Moalla, Maxime Ronot, Angela Lamarca
Purpose:Tumor growth rate (TGR) represents the percentage change in tumor volume per month (%/m). Previous results from the GREPONET study showed that TGR measured after 3 months (TGR3m) of starting systemic treatment (ST) or watch and wait (WW) was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::674287bc5ea64220cdb941f5b6472b9d
https://doi.org/10.1158/1078-0432.c.6527771.v1
https://doi.org/10.1158/1078-0432.c.6527771.v1
Autor:
Clarisse Dromain, Marianne Pavel, Frederico Costa, Anders Sundin, Eric Baudin, Niklaus Scaefer, Louis de Mestier, Hector Vidal Trueba, Naik Vietti Violi, Philip Borg, Regis Otaviano Franca Bezerra, Luciana Carvhalo, Pavan Najran, Daniela Pezzutti, Carlos Lopez Lopez, Marta Opalinska, Joakim Crona, Salma Moalla, Maxime Ronot, Angela Lamarca
Supplementary Table 1: Baseline characteristics of patients for external validation (Aim-2). Supplementary Table 2: Univariate and Multivariable Cox regression for Progression-Free Survival (Aim-2).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::451ca065816c2ee1e5a1339356d4d85c
https://doi.org/10.1158/1078-0432.22471085
https://doi.org/10.1158/1078-0432.22471085
Autor:
Eric Baudin, Salma Moalla, Clarisse Dromain, Maxime Ronot, Pavan Najran, Joakim Crona, Philip Borg, Frederico Costa, Niklaus Scaefer, Regis Otaviano Franca Bezerra, Carlos López, Marta Opalinska, Louis de Mestier, Daniela Pezzutti, Angela Lamarca, Luciana Carvhalo, Anders Sundin, Naik Vietti Violi, Marianne Pavel, Hector Vidal Trueba
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 25(22)
Purpose: Tumor growth rate (TGR) represents the percentage change in tumor volume per month (%/m). Previous results from the GREPONET study showed that TGR measured after 3 months (TGR3m) of starting systemic treatment (ST) or watch and wait (WW) was
Autor:
Hector Vidal-Trueba, Pavan Najran, Anders Sundin, Maxime Ronot, Franca Bezerra Regis Otaviano, Philip Borg, Clarisse Dromain, Marta Opalinska, Salma Moalla, Naik Vietti-Violi, Eric Baudin, Frederico Costa, Niklaus Scaefer, Luciana Carvhalo, Mestier Louis de, Carlos Lopez-Lopez, Daniela Pezzutti, Angela Lamarca, Joakim Crona, Marianne Pavel
Publikováno v:
Endocrine Abstracts.